Point72 Asset Management
CRVO icon

Point72 Asset Management’s CervoMed CRVO Stock Holding History

Point72 Asset Management’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10,000
Closed -$233K – 1942
2024
Q1 		$233K Buy
+10,000
New +$133K ﹤0.01% 1860

Other funds holding CRVO

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CAM
Crown Advisors Management Larkspur, California $151M AUM 73.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management's CRVO Position: Q2 2024 in Review

Point72 Asset Management sold out of CervoMed (CRVO) in Q2 2024, closing a stake of 10,000 shares — an estimated $233K sold.

Point72 Asset Management first reported a position in CRVO in Q1 2024 and held it in 1 quarter. The position peaked at $233K in Q1 2024. 38 funds tracked by Wall St. Rank hold CRVO as of Q2 2024.

  • Point72 Asset Management reported no remaining CervoMed position as of Q2 2024 after selling out during the quarter.
  • Point72 Asset Management sold 10,000 CervoMed shares in Q2 2024, an estimated $233K.
  • Point72 Asset Management first reported a position in CervoMed in Q1 2024 and held it in 1 quarter.
  • Point72 Asset Management's CervoMed position peaked at $233K in Q1 2024.
  • 38 funds tracked by Wall St. Rank held CervoMed as of Q2 2024.

Based on Point72 Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.